VILNIAUS UNIVERSITETAS

Their core work

Vilnius University is Lithuania's leading research university with deep capabilities in advanced materials science, electrochemistry, and biophysical technologies. Their labs work on functional materials — from multiferroics and metal oxides to smart electrodes for electrochemical processing and sensing. They also maintain strong programs in droplet microfluidics for single-cell analysis and directed protein evolution, alongside significant contributions to European research policy, ethics, and open science infrastructure. Their research spans from fundamental physics and chemistry to biomedical applications like early-stage cancer detection.

What they specialise in

How they've shifted over time

In 2015–2018, Vilnius University focused heavily on fundamental materials research (multiferroics, smart alloys), research infrastructure access (laser labs, planetary science instruments, HPC), and marine enzyme bioprospecting. From 2018 onward, the focus shifted decisively toward applied biomedical technologies — droplet microfluidics for epigenetic tracking and protein engineering, nanostructured sensors for cancer detection, and OLED materials — while also expanding into research policy, ethics, and data standardization for personalized medicine. The university moved from being primarily a materials physics contributor to combining that expertise with biological applications and science governance.

Vilnius University is converging its materials science and microfluidics strengths toward biomedical applications — particularly single-cell diagnostics and personalized medicine — making them a strong partner for health-tech consortia.

How they like to work

Vilnius University primarily operates as a contributing partner (34 of 44 projects), but has demonstrated real coordination capacity with 8 coordinated projects, including their flagship EpiTrack grant (EUR 2.5M ERC). With 548 unique consortium partners across 55 countries, they are a well-connected hub rather than a loyal-partner type — they bring wide European network reach to any consortium. Their participation spans both large infrastructure consortia (LASERLAB-EUROPE, AIDA-2020) and focused MSCA mobility projects, indicating flexibility across consortium sizes.

With 548 unique partners across 55 countries, Vilnius University has one of the broadest collaboration networks among Baltic universities. Their partnerships span all major EU research nations with no strong geographic bias, reflecting their role in large pan-European infrastructure and MSCA networks.

What sets them apart

Vilnius University is the strongest H2020 research actor in Lithuania, combining hard materials science (electrochemistry, ferroics, nanostructures) with modern biophysical techniques (droplet microfluidics, single-cell epigenomics) — a rare combination. Their ERC-funded EpiTrack project demonstrates they can win and lead top-tier competitive grants, not just participate. For consortium builders, they offer both scientific depth and a gateway to the Baltic research ecosystem at competitive cost levels compared to Western European partners.

Highlights from their portfolio

• EpiTrack
  Their largest project (EUR 2.5M, coordinated) — an ERC grant combining droplet microfluidics with epigenetic DNA mark tracking at single-cell resolution.
• SMARTELECTRODES
  Coordinated MSCA-RISE project showcasing their core electrochemistry expertise across metallic foams, semiconductor electrodes, and sensing applications.
• INMARE
  Industrial marine enzyme discovery project connecting their chemistry capabilities to blue bioeconomy applications — an unusual cross-sector reach for a physics-strong university.